Bohn E, Schmitt E, Bielfeldt C, Noll A, Schulte R, Autenrieth I B
Max-von-Pettenkofer-Institut, Ludwig-Maximilians-University, Munich, Germany.
Infect Immun. 1998 May;66(5):2213-20. doi: 10.1128/IAI.66.5.2213-2220.1998.
Endogenous interleukin-12 (IL-12) mediates protection against Yersinia enterocolitica in C57BL/6 mice by triggering gamma interferon (IFN-gamma) production in NK and CD4+ T cells. Administration of exogenous IL-12 confers protection against yersiniae in Yersinia-susceptible BALB/c mice but exacerbates yersiniosis in resistant C57BL/6 mice. Therefore, we wanted to dissect the different mechanisms exerted by IL-12 during Yersinia infections by using different models of Yersinia-resistant and -susceptible mice, including resistant C57BL/6 mice, susceptible BALB/c mice, intermediate-susceptible wild-type 129/Sv mice, 129/Sv IFN-gamma-receptor-deficient (IFN-gamma R-/-) mice and C57BL/6 tumor necrosis factor (TNF) receptor p55 chain-deficient (TNFR p55-/-) mice. IFN-gamma R-/- mice turned out to be highly susceptible to infection by Y. enterocolitica compared with IFN-gamma R+/+ mice. Administration of IL-12 was protective in IFN-gamma R+/+ mice but not in IFN-gamma R-/- mice, suggesting that IFN-gamma R-induced mechanisms are essential for IL-12-induced resistance against yersiniae. BALB/c mice could be rendered Yersinia resistant by administration of anti-CD4 antibodies or by administration of IL-12. In contrast, C57BL/6 mice could be rendered more resistant by administration of transforming growth factor beta (TGF-beta). Furthermore, IL-12-triggered toxic effects in C57BL/6 mice were abrogated by coadministration of TGF-beta. While administration of IL-12 alone increased TNF-alpha levels, administration of TGF-beta or TGF-beta plus IL-12 decreased both TNF-alpha and IFN-gamma levels in Yersinia-infected C57BL/6 mice. Moreover, IL-12 did not induce toxicity in Yersinia-infected TNFR p55-/- mice, suggesting that TNF-alpha accounts for IL-12-induced toxicity. Taken together, IL-12 may induce different effector mechanisms in BALB/c and C57BL/6 mice resulting either in protection or exacerbation. These results are important for understanding the critical balance of proinflammatory and regulatory cytokines in bacterial infections which is decisive for beneficial effects of cytokine therapy.
内源性白细胞介素-12(IL-12)通过触发自然杀伤细胞(NK)和CD4⁺ T细胞产生γ干扰素(IFN-γ),介导C57BL/6小鼠抵御小肠结肠炎耶尔森菌。给予外源性IL-12可使对耶尔森菌易感的BALB/c小鼠获得对耶尔森菌的保护,但会加剧抗性C57BL/6小鼠的耶尔森菌病。因此,我们想通过使用不同的对耶尔森菌具有抗性和易感性的小鼠模型,包括抗性C57BL/6小鼠、易感BALB/c小鼠、中度易感的野生型129/Sv小鼠、缺少129/Sv IFN-γ受体(IFN-γ R⁻/⁻)的小鼠以及C57BL/6肿瘤坏死因子(TNF)受体p55链缺陷(TNFR p55⁻/⁻)小鼠,来剖析IL-12在耶尔森菌感染期间发挥的不同机制。与IFN-γ R⁺/⁺小鼠相比,IFN-γ R⁻/⁻小鼠对小肠结肠炎耶尔森菌感染高度易感。给予IL-12对IFN-γ R⁺/⁺小鼠有保护作用,但对IFN-γ R⁻/⁻小鼠则无保护作用,这表明IFN-γ R诱导的机制对于IL-12诱导的抗耶尔森菌抗性至关重要。给予抗CD4抗体或IL-12可使BALB/c小鼠对耶尔森菌产生抗性。相反,给予转化生长因子β(TGF-β)可使C57BL/6小鼠更具抗性。此外,联合给予TGF-β可消除IL-12在C57BL/6小鼠中引发的毒性作用。单独给予IL-12会升高TNF-α水平,而给予TGF-β或TGF-β加IL-12则会降低耶尔森菌感染的C57BL/6小鼠中的TNF-α和IFN-γ水平。此外,IL-12在耶尔森菌感染的TNFR p55⁻/⁻小鼠中未诱导毒性,这表明TNF-α是IL-12诱导毒性的原因。综上所述,IL-12可能在BALB/c和C57BL/6小鼠中诱导不同的效应机制,从而导致保护或病情加重。这些结果对于理解细菌感染中促炎细胞因子和调节性细胞因子的关键平衡非常重要,而这种平衡对于细胞因子治疗的有益效果起着决定性作用。